Indian private equity firm ChrysCapital has raised $700 million in new funds, allowing the firm to maintain its stake in India's National S...

Following the acquisition, ProHance aims to build on its success and plans to strategically expand into important markets such as the Phili...

In March, Abu Dhabi Investment Authority (ADIA), the Gulf Sovereign wealth fund (SWF), had invested $500 million in the company.

Xoriant provides services and solutions focused on digital product engineering, cloud infrastructure and operation across sectors like BFSI...

ResultsCX provides automation-driven customer support, acquisition, enrolment, retention, membership assistance, technical support and tran...

The incoming investors have purchased a portion of the shares held by QuEST’s co-founders and management team, the company said, adding tha...

Proceeds from the deal will be primarily utilised to expand capacity, according to Amit Ramani, chief executive of Awfis.

The five-year-old LivGuard was founded by Rakesh Malhotra and Navneet Kapoor, the former founder promoters of Luminous Power.

ChrysCap, which had launched the fundraising in August last year, raised the money in four months, one of the fastest fundraising procedure...

GeBBS is a leading provider of revenue cycle management (RCM) solutions for the healthcare industry in the US.

A ChrysCapital spokesperson has confirmed the development while Bhattacharya did not respond to calls.

The funds will be used to expand the eyecare chain run by publicly traded unit Dr Agarwal’s Eye Hospital Ltd into new geographies.

Founded by Genpact’s former CEO, Pramod Bhasin and Vikram Gandhi who was previously with Credit Suisse and Morgan Stanley, Asha Impact foll...

CavinKare has bagged Rs 250 crore of private equity investments from Mauritius-based firm ChrysCapital in a "structured deal" in order to s...

FMCG firm CavinKare today said Mauritius-based private equity firm ChrysCapital has invested Rs 250 crore in it for an undisclosed stake

At this price, the company is being valued at Rs 1,200 crore, which is 50% more than its previous valuation in March 2012.

Private Equity (PE) investments in the domestic healthcare and pharma industry have touched around $400 million during the first nine month...